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Human papillomavirus (HPV) is the most common sexually
transmitted infection in female adolescents. The highest
infection rate is found among individuals aged 15e24 years,1
and the HPV vaccine represents an opportunity to reduce the
burden of cervical cancer caused by HPV types 16 and 18.2 The
WorldHealthOrganizationhasdefinedgirls aged9e13years as
the priority target for HPV vaccination.3 In Italy, in accordance
with international public health guidelines, HPV vaccination
was freeandactivelyoffered to all girlsduring their 12thyearof
life (from the completion of 11 years until the age of 12 years)
between 2007 and 2008, establishing a target vaccination
coverage of 95% within 5 years of the start of the campaign.4,5
However, despite several promotional activities, vaccina-
tion coverage is largely unsatisfactory, ranging from 25% to
82% between regions.6
The aims of this study were to determine HPV vaccination
coverage within a cohort of girls born in 1999, to describe
parents' attitudes towards HPV vaccination and their* Corresponding author. Department of Sciences for Health Promotion
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parents' hesitancy towards HPV vaccination, and to examine
the effect of an intervention providing parents with informa-
tion to promote vaccine access.Methods
This study was conducted within the local health units (LHUs)
of Palermo, Italy, including 1750 out of 1796 girls born in 1999.
The exclusion criteria were: presence of contraindications
(n ¼ 10), previous anaphylactic reaction (n ¼ 8), absence of
contact information (n ¼ 15), and foreign origin of girls (six
subjects excluded because of possible discrepancy with HPV
vaccination policy in their country of origin).
HPV vaccination status was determined by consulting the
official vaccination registry. All girls were considered to be
fully vaccinated when they had received three doses of vac-
cine (n¼ 627; 35.8%). Using a block randomisationmethod (1:1,
block size of two) for two groups, the 1123 (64.2%) girls who
had not been vaccinated at all or who had only received the
first or second dose were divided at random into two groups:
 the intervention group (n ¼ 561) received a standardised
telephone call from health personnel to administer a
questionnaire to their parents;
 the control group (n¼ 562) did not receive any intervention.
From January to June 2013, the parents of girls in the
intervention group (n ¼ 561) were interviewed through a
telephone semi-structured questionnaire, validated byand Mother Child Care, University of Palermo, Via del Vespro, 133,
lsevier Ltd. All rights reserved.
Table 1 e Knowledge about human papillomavirus (HPV)
infection and route of transmission.
Question Correct
answer
n (%)
Incorrect
answer
n (%)
1. HPV infection is rare 252 (55.5) 202 (44.4)
2. HPV infection is sexually
transmitted
316 (69.6) 138 (30.4)
3. HPV infection is transmitted
through infected blood
236 (52.0) 218 (48.0)
4. HPV infection is transmitted
through close contact with an
infected person (hands, sneezes
or kisses)
368 (81.1) 86 (18.9)
5. HPV infection is transmitted
through common restrooms, and
contaminated fomites (such as
clothing and towels)
278 (61.2) 176 (38.8)
6. HPV infection is responsible for 424 (93.4) 30 (6.6)
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timenti Sociali, Social Investments Study Centre), and
comprising multiple choice questions (seven on vaccinations
and 13 onHPV infection). At least three attemptsweremade to
contact the parents of these girls (at lunch time, afternoon and
in the evenings). Interviewers explained the purpose of the
study and obtained verbal consent from participants.
At the end of the interview, standardised counselling was
provided to parents in order to explain themain route of virus
transmission, the associated risk factors and the timing of
vaccination, highlighting the fact that HPV vaccination was
free of charge for the target age group. In addition, the parents
were urged to vaccinate their daughters through a scheduled
appointment.
One year after the interviews (June 2014), in the re-
assessment of vaccination schedules of the study population,
vaccination coverage pre-intervention and postintervention
were evaluated and compared between the two groups.
cervical cancer
7. HPV infection is responsible for
genital warts
293 (64.5) 161 (35.5)
8. HPV can only infect women 237 (52.2) 217 (47.8)
9. Spontaneous regression of HPV
infection is possible
133 (29.3) 321 (70.7)
10. HPV asymptomatic infection is
possible
361 (79.5) 93 (20.5)
11. HPV infection could persist over
time
353 (77.7) 101 (22.3)
12. Effectiveness of HPV
vaccination is greater when
administered before starting
sexual activity
331 (72.9) 123 (27.1)
13. HPV vaccination protects
against HPV serotypes
responsible for the development
of most cervical cancers
435 (95.8) 19 (4.2)Results
Of the 561 families in the intervention group, 454 (80.9%)
completed the questionnaires. One hundred and seven (19.1%)
families were excluded because they refused to participate
(n ¼ 28) or they were not available for interview (n ¼ 79).
As determined by the survey, 31.7% of the parents trusted
vaccination, and 28% were hesitant regarding some vaccina-
tions. More than one-third (40%) of parents agreed that
mandatory vaccination was the best strategy to increase
vaccination coverage.
Nearly two-thirds (62.3%) of parents declared that their
main source of information regarding vaccination was a
healthcare worker (HCW), particularly those working in the
vaccine centre at the LHU. Mass media (particularly the
Internet, television and newspapers) were the main source of
information for 28.6% of parents, followed by family or friends
(4.6%) and school (4.5%).
Among those who consulted HCWs, 55% reported that the
information they receivedwas adequate, while 44.5% (n¼ 202)
reported that the information was scarce and generic.
At least one HCW encouraged HPV vaccination for 44.1% of
the interviewed parents. However, 32.1% of parents said that
they had never talked about vaccination with any HCWs, and
12.1% declared that different HCWs expressed different
opinions; only 3.3% of parents stated that the HCWs they
consulted did not express any opinion on the subject. Finally,
8.4% of parents reported that the HCWs they consulted did not
recommend HPV vaccination.
The use of condoms was reported as the best preventive
measure for HPV infection by 63.2% of parents, while 21.6%
believed that the risk of contagion may not be eliminated
completely in sexually active individuals. Of the parents,
11.9% had no knowledge about the mode of transmission of
HPV and 3.3% said that intimate hygiene was the only pre-
ventive measure.
The results regarding knowledge of HPV infection are
summarised in Table 1.
Regarding invitation for HPV vaccination by the vaccina-
tion centre, 233 (51.3%) girls were invited to receive HPVvaccination and 221 (48.7%) girls did not receive an invitation.
The majority (91.2%) of girls did not receive a reminder from
the Palermo LHUs.
One year after the questionnaire (June 2014), the official
vaccination registry was consulted to re-examine HPV vacci-
nation coverage of the 454 girls whose parents completed the
questionnaire, and to compare this with HPV vaccination
coverage of the 669 girls whose parents did not receive any
form of intervention (the 562 girls in the control group and the
107 girls who did not take part in the survey).
In the non-intervention group, only 69 (10.3%) girls
completed the vaccination schedule. In the intervention
group, 123 (27.1%) girls completed the vaccination schedule
after the questionnaire and counselling (P < 0.0001). In
particular, three subgroups of parents reported a significant
change in their attitude towards HPV prevention, and
ensured that their daughters completed the vaccination
schedule:
 59 out of 202 parents who considered HPV to be a rare
disease (29.2%; P < 0.0005, McNemar test);
 42 out of 138 parents who did not believe that sexual ac-
tivity represents the principal route of transmission (30.4%;
P < 0.0005, McNemar test); and
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be transmitted through close contact with an infected
person (31.4%; P ¼ 0.004, McNemar test).Discussion
Recognition of the main reasons for hesitancy regarding HPV
vaccination is fundamental to develop tailored and innovative
public health strategies.4,7,8 Despite the fact that this survey
was only undertaken in one region in Italy, it included all girls
born in 1999 without stratification for social/economical and
cultural background, thus testing the efficacy of the pro HPV
vaccination campaigns and the postsurvey intervention
beyond financial and educational barriers.
The main source of information was predominantly
represented by HCWs; however, the parents had uncon-
solidated and partial knowledge about the route of trans-
mission of infection. Moreover, 45% of the sample was
dissatisfied, as they had received little or no information
from HCWs regarding HPV vaccination; this could represent
an important reason for hesitancy. Only 44% of the parents
in this study reported that they had received positive advice
from clinicians about vaccination. This result is confirmed
by the ‘Valore project’,9 which showed that HCWs only
recommended vaccination in 31% of cases of unvaccinated
girls.
The ‘Valore project’9 showed that Italian pre-adolescents
are interested in HPV vaccination and in acquiring addi-
tional information, and identified school as a setting where
they are free to express themselves without fear of being
judged, especially if the dialogue takes place with trusted
teachers. These results suggest the possible role of schools in
the provision of information about HPV vaccination.
In this study, the re-examination of vaccination schedules
and vaccine coverage 1 year after the interview demonstrated
that parent counselling provided important information about
HPV infection and prevention, and increased overall HPV
vaccination coverage among unvaccinated or incompletely
vaccinated girls.
In particular, the intervention group exhibited a significant
change in attitudes towards HPV vaccination, and vaccination
coverage almost tripled compared with the control group.
These results are particularly significant if one considers that
the provision of clear unambiguous information about HPV
transmission was fundamental in influencing parental choice
to ensure complete vaccination of their daughters. This has
been confirmed in other national studies, which found that
inadequate formation of families and inconsistent messages
regarding HPV vaccination may contribute to refusal of HPV
vaccination.9
Integrated curricular education or training for all HCWs
involved in HPV vaccination is strongly recommended,
particularly regarding the importance of providing correct and
consistent information.Author statements
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